| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Seelos Therapeutics, Inc.
13G
SEELQ · 81577F406
|
10.7% |
11/25/2024
Event 11/14/2024
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.